Ординатура / Офтальмология / Английские материалы / Principles Of Medical Statistics_Feinstein_2002

Aubert, C., Rouge, F., and Voulot, C. New variants of the B16 melanoma: tumorigenicity and metastatic properties under different culture conditions. J. Natl. Cancer Inst. 1990; 82:952–958. [28]

Avis, N.E., Brambilla, D., McKinlay, S.M., and Vass, K. A longitudinal analysis of the association between menopause and depression. Results from the MassachusettsWomen’s Health Study. Ann. Epidemiol. 1994; 4:214–220. [22]

Avvisati, G., Ten Cate, J.W., Buller, H.R., and Mandelli, F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet 1989; 2:122–124. [15]

Bab bage, C. Quoted in Moroney, M.J. The World of Mathematics. Vol. 3. New York: Simon and Schuster, 1956, p. 1487. [6]

Baehr, L. and Ahern, D.K. Statistical problems with small sample size (Letter to editor). Am. J. Psychiatry 1993; 150:356. [23]

Baer, F.M., Smolarz, K., Jungehulsing, M. et al. Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 9mTc- methoxyisobutyl-isonitrile SPECT. Am. Heart J. 1992; 123:1636–1645. [16]

Bailar, B.A. Just what do I get for my ASA dues? Amstat News 1992; 185:4. [9]

Bailey, W.C., Higgins, D.M., Richards, B.M., and Richards, J.M., Jr. Asthma severity: a factor analytic investigation. Am. J. Med. 1992; 93:263–269. [28]

Bale, S.J., Dracopoli, N.C., Tucker, M.A. et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1P. N. Engl. J. Med. 1989; 320:1367–1372. [17]

Bao, W., Srinivasan, S.R., Valdez, R., Greenlund, K.J., Wattigney, W.A., and Berenson, G.S. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease. JAMA 1997; 278:1749–1754. [22]

Barnard, G.A. Sequential tests in industrial statistics. J. Roy. Statist. Soc. 1946; 8(Suppl):1–26. [25] Barnett, R.N. with contributions by I.M. Weisbrot. Clinical Laboratory Statistics. 2nd ed. Boston:

Little Brown & Co., 1979. [20,21]

Baron, J.A., Bulbrook, R.D., Wang, D.Y., and Kwa, H.G. Cigarette smoking and prolactin in women. Br. J. Med. 1986; 293:482–483. [3]

Baxt, W.G. Use of an artificial neural network for the diagnosis of myocardial infarction. Ann. Intern. Med. 1991; 115:843–848. [21]

Beckmann, M.L., Gerber, J.G., Byyny, R.L., LoVerde, M., and Nies, A.S. Propranolol increases pros - tacyclin synthesis in patients with essential hypertension. Hypertension 1988; 12:582–588. [19] Begg, C.B. Advances in statistical methodology for diagnostic medicine in the 1980’s. Stat. Med.

1991; 10:1887–1895. [21]

Benedetti, T.J. Treatment of pre-term labor with the beta-adrenergic agonist ritodrine. Letter to editor. N. Engl. J. Med. 1992; 327:1758–1760. [23]

Berkman, P.L. Life stress and psychological well-being: A replication of Langner’s analysis of midtown Manhattan society. J. Health Soc. Behav. 1971; 23:35–45. [15]

Berkson, J. and Gage, R.P. Calculation of survival rates for cancer. Proc. Staff Meetings Mayo Clin. 1950; 25:270–286. [22]

Berry, D.A. A case for Bayesianism in clinical trials. Stat. in Med. 1993; 12:1377–1393. [11] Bierman, E.L. Law of the initial value (Letter to editor). Lancet 1976; 323:1076–1077. [19] Bioequivalence of levothyroxine preparations: Issues of science, publication, and advertising (Letter

to editor). JAMA 1997; 278:895–900. [24]

Birkelo, C.C., Chamberlain, W.E., Phelps, P.S., Schools, P.E., Zacks, D., and Yerushalmy, J. Tubercu - losis case finding. A comparison of the effectiveness of various roentgenographic and photofluorographic methods. JAMA 1947; 133:359–365. [21]

Blackwelder, W.C. “Proving the null hypothesis” in clinical trials. Controlled Clin. Trials 1982; 3:345–353. [24]

Blackwelder, W.C. and Chang, M.A. Sample size graphs for “proving the null hypothesis.” Controlled Clin. Trials 1984; 5:97–105. [24]

Bland, J.M. and Altman, D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307–310. [20]

© 2002 by Chapman & Hall/CRC

Bland, J.M. and Altman, D.G. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Computations Biol. Med. 1990; 20:337–340. [20,29]

Blankenhorn, D.H., Brooks, S.H., Selzer, R.H., and Barndt, R., Jr. On the relative importance of Ps and rs (Letter to editor). Circulation 1978; 57:1232. [19]

Blyth, C.R. and Still, H.A. Binomial confidence intervals. J. Am. Stat. Assn. 1983; 78:108–116. [8] Bobbio, M., Demichelis, B., and Giustetto, G. Completeness of reporting trial results: effect on

physicians’ willingness to prescribe. Lancet 1994; 343:1209–1211. [10]

Boffey, P.M. Anatomy of a decision. How the nation declared war on swine flu. Science 1976; 192:636–641. [6]

Bogardus, S.T., Concato, J., Feinstein, A.R. Clinical epidemiological quality in molecular genetic research. The need for methodological standards. JAMA 1999; 281:1919–1926. [21]

Boneau, C.A. The effects of violations of assumptions underlying the t test. Psychol. Bull. 1960; 57:49–64. [13]

Bonferroni, C.E. (The original publication, in a 1936 Italian economics journal, is not available. The strategy is well discussed in Miller, R.G. Simultaneous Statistical Inference. New York: McGraw-Hill, 1966.) [25]

Borenstein, M. Planning for precision in survival studies. J. Clin. Epidemiol. 1994; 47:1277–1285. [22] Boston Collaborative Drug Surveillance Program. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, breast tumours. Lancet 1973; 1:1399–1404.

[25]

Boston Collaborative Drug Surveillance Program. Reserpine and breast cancer. Lancet 1974; 2:669–671. [10,25]

Boucher, K.M., Slattery, M.L., Berry, T.D., Quesenberry, C. and Anderson, K. Statistical methods in epidemiology: A comparison of statistical methods to analyze dose-response and trend analysis in epidemiologic studies. J. Clin. Epidemiol. 1998; 51:1223–1233. [27]

Box G.E., Hunter, W.G., and Hunter, J.S. Statistics for Experiments. New York: John Wiley and Sons, 1978. [19]

Box, J.F. and Fisher, R.A. The Life of a Scientist. New York: John Wiley and Sons, 1978. [11] Bradley, J.V. Distribution-free statistical tests. Englewood Cliffs, NJ: Prentice-Hall, Inc., 1968.

[14,15,27]

Brand, D.A., Frazier, W.H., Kohlhepp, W.C. et al. A protocol for selecting patients with injured extremities who need X-rays. N. Engl. J. Med. 1982; 306:333–339. [21]

Brand, R. and Kragt, H. Importance of trends in the interpretation of an overall odds ratio in the meta-analysis of clinical trials. Stat. Med. 1992; 11:2077–2082. [25]

Braun, H.I. (Ed.). The Collected Works of John W. Tukey: Vol. VIII, Multiple Comparisons: 1948–1983. London: Chapman and Hall, 1994. [25]

Brenner, H. and Gefeller, O. Chance-corrected measures of the validity of a binary diagnostic test. J. Clin. Epidemiol. 1994; 47:627–633. [21]

Breslow, N. Comparison of survival curves. In Buyse, M.E., Staquet, M.J., and Sylvester, R.J. (Eds.). Cancer Clinical Trials Methods and Practice. London: Oxford University Press, 1984. [22]

Breslow, N.E. and Day, N.E. Statistical Methods in Cancer Research. Vol. I. The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, 1980. [17,26]

Brook, R.H. Practice guidelines and practicing medicine. JAMA 1989; 262:3027–3030. [21]

Brophy, J.M. and Joseph, L. Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes. JAMA 1995; 273:871–875. [11]

Bross, I.D.J. How to use ridit analysis. Biometrics 1958; 14:18–38. [15]

Browman, G.P., Levine, M.N., Hodson, D.I., Sathya, J., Russell, R., Skingley, P., Cripps, C., Eapen, L., and Girard, A. The head and neck radiotherapy questionnaire: A morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J. Clin. Oncol. 1993; 11:863–872. [29]

Brown, B.W. and Russell, K. Methods correcting for multiple testing: operating characteristics. Stat. Med. 1997; 16:2511–2528. [25]

Brown, C.C. The validity of approximation methods for interval estimation of the odds ratio. Am. J. Epidemiol. 1981; 113:474–480. [17]

© 2002 by Chapman & Hall/CRC

Brown, S.M., Selvin, S., and Winkelstein, W., Jr. The association of economic status with the occurrence of lung cancer. Cancer 1975; 36:1903–1911. [15]

Bryant, G.D. and Norman, G.R. Expressions of probability: Words and numbers (Letter to the editor). N. Engl. J. Med. 1980; 302:411. [6]

Bucher, H.C., Weinbacher, M., and Gyr, K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. Br. Med. J. 1994; 309:761–764. [10]

Burnand, B. and Feinstein, A.R. The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease. J. Clin. Epidemiol. 1992; 45:929–940. [17]

Burnand, B., Kernan, W., and Feinstein, A.R. Indexes and boundaries for “quantitative significance” in statistical decisions. J. Clin. Epidemiol. 1990; 43:1273–1284. [10,16,17,19,20]

Calandra, T., Gerain, J., Heumann, D., Baumgartner, J-D., Glauser, M.P., and the Swiss-Dutch J5 Immunoglobulin Study Group. High circulating levels of Interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines. Am. J. Med. 1991; 91:23–29. [27]

Campbell, M.J. and Gardner, M.J. Calculating confidence intervals for some non-parametric analyses. Br. Med. J. 1988; 296:1454–1456. [15]

Cancer Letters. 1994; 77:139–211 (These pages contain a series of pertinent papers on the cited topics). [21]

Capdevila, J.A., Almirante, B., Pahissa, A., Planes, A.M., Ribera, E., and Martinez-Vazquez, J.M. Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch. Intern. Med. 1994; 154:411–415. [22]

Cappuccio, F.P., Strazzullo, P., Farinaro, E., and Trevisan, M. Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA 1993; 270:354–359. [16]

Carette, S., Marcoux, S., Truchon, R., Grondin, C., Gagnon, J., Allard, Y., and Latulippe, M. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. Nnew Engl. J. Med. 1991; 325:1002–1007. [24]

Carlin, J.B. Meta-analysis for 2 × 2 tables: A Bayesian approach. Stat. Med. 1992; 11:141–158. [25] Carpenter, J. and Bithell, J. Bootstrap confidence intervals: When, which, what? A practical guide

for medical statisticians. Statist. Med. 2000; 19:1141–1164. [7]

Carson, C.A., Taylor, H.R., McCarty, D.J., and Zimmet, P. Age-standardization in epidemiological data (Letter to editor). Int. J. Epidemiol. 1994; 23:643–644. [26]

Chalmers, T.C. Meta-analytic stimulus for changes in clinical trials. Stat. Methods Med. Res. 1993; 2:161–172. [25]

Chambers, J.M., Cleveland, W.S., Kleiner, B., and Tukey, P.A. Graphical Methods for Data Analysis. Boston: Duxbury Press, 1983, 60. [16]

Chan, C.K., Feinstein, A.R., Jekel, J.K., and Wells, C.K. The value and hazards of standardization in clinical epidemiologic research. J. Clin. Epidemiol. 1988; 41:1125–1134. [26]

Chandra Sekhar, C., Indrayan, A., and Gupta, S.M. Development of an index of need for health resources for Indian states using factor analysis. Int. J. Epidemiol. 1991; 20:246–250. [28] Chappell, R. and Branch, L.G. The Goldilocks dilemma in survey design and its solution. J. Clin.

Epidemiol. 1993; 46:309–312. [22]

Cherfas, J. University restructuring based on false premise? Recent studies contest the British government’s argument that big science departments are better than small ones. Science 1990; 247:278. [19]

Chiang, C.L. A stochastic study of the life table and its application. III. The follow-up study with the consideration of competing risks. Biometrics 1961; 17:57–78. [22]

Chow, S.C. and Liu, J.P. Statistical consideration in bioequivalence trials. Biometric Bull. 1992; 9:19 (Abstract). [24]

Ciampi, A., Schiffrin, A., Thiffault, Q.H., Weitzner, G., Poussier, P., and Lalla, D. Cluster analysis of an insul-dependent diabetic cohort towards the definition of clinical subtypes. J. Clin. Epidemiol. 1990; 43:701–714. [28]

Cicchetti, D.V. Assessing inter-rater reliability for rating scales: Resolving some basic issues. Br. J. Psychiatry 1976; 129:452–456. [20]

© 2002 by Chapman & Hall/CRC

Cicchetti, D.V., Lyons, N.S., Heavens, R., Jr., and Horwitz, R. A computer program for correlating pairs of variables when one is measured on an ordinal scale and the other on a continuous scale of measurement. Educ. Psych. Meas. 1982; 42:209–213. [27]

Civetta, J.M., Hudson-Civetta, J.A., Kirton, O., Aragon, C., and Salas, C. Further appraisal of Apache II limitations and potential. Surg. Gynecol. Obstet. 1992; 175:195–203. [29]

Clark, H.H. Comment on “Quantifying probabilistic expressions.” Statist. Sci. 1990; 5:12–16. [6] Clarke, M.R. Statistics and ethics in medical research (Letter to editor). Br. Med. J. 1981; 282:480. [23] Clarke, P.R.F. and Spear, F.G. Reliability and sensitivity in the self-assessment of well-being. Bull.

Brit. Psychol. Soc. 1964; 17:18A. [15]

Cleveland, W.S. Elements of Graphing Data. 2nd ed. Summit, NJ: Hobart Press, 1994. [5] Cleveland, W.S. and McGill, R. Graphical perception: Theory, experimentation, and application to

the development of graphical methods. J. Am. Statist. Assn. 1984; 79:531–554. [16] Cliff, N. Comment on “quantifying probabilistic expressions.” Statist. Sci. 1990; 5:16–18. [6]

Clopper, C.J. and Pearson, E.S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26:404–413. [8]

COBALT Investigators. Continuous infusion versus double-bolus administration of alteplace. A comparison of continuous infusion of alteplace with double-bolus administration for acute myocardial infarction. N. Engl. J. Med. 1997; 337:1124–1130. [24]

Cochran, W.G. Some methods of strengthening the common χ 2 tests. Biometrics 1954; 10:417–451. [14,26]

Cochran, W.G. and Cox, G.M. Experimental Designs. New York: John Wiley and Sons, 1950. [11] Cohen, J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960; 20:37–46. [20] Cohen, J. Statistical Power Analysis for the Behavioral Sciences. Rev. ed. New York: Academic Press,

1977. [10,19,20,23]

Coldman, A.J. and Elwood, J.M. Examining survival data. Canad. Med. Assn. J. 1979; 121:1065–1071. [22]

Cole, P. The hypothesis generating machine. Epidemiology 1993; 4:271–273. [25]

Cole, P. and MacMahon, B. Attributable risk percent in case-control studies. Brit. J. Prev. Soc. Med. 1971; 25:242–244. [17]

Colquhoun, D. Re-analysis of clinical trial of homoeopathic treatment of fibrositis (Letter to editor). Lancet 1990; 336:441–442. [15]

Concato, J., Feinstein, A.R., and Holford, T.R. The risk of determining risk with multivariable models. Ann. Intern. Med. 1993; 118:201–210. [8,19]

Concato, J., Horwitz, R.I., Feinstein, A.R., Elmore, J.G., and Schiff, S.F. Problems of comorbidity in mortality after prostatectomy. JAMA 1992; 267:1077–1082. [26]

Conover, W.J. Practical Non-Parametric Statistics. New York: John Wiley and Sons, 1980. [27] Cook, R.J. and Farewell, V.T. Multiplicity considerations in the design and analysis of clinical trials.

J. R. Statist. Soc. A. 1996; 159:93–110. [25]

Copas, J. (Letter to editor). The Prof. Statist. 1990; 9:3. [9]

Cormack, R.M. A review of classification. J. Roy. Statist. Soc., A. 1971; 134:321–367. [28]

Cormack, R.S. and Mantel, N. Fisher’s exact test: The marginal totals as seen from two different angles. Statistician 1991; 40:27–34. [14]

Cornbleet, P.J. and Shea, M.C. Comparison of product moment and rank correlation coefficients in the assessment of laboratory method-comparison data. Clin. Chem. 1978; 24:857–861. [21]

Cornfield, J. Quoted in Wynder, E.L. Workshop on guidelines to the epidemiology of weak associations. Prev. Med. 1987; 16:139–141. [17]

Cornfield, J. A method of estimating comparative rates from clinical data. Applications to cancer of the lung, breast and cervix. J. Natl. Cancer Inst. 1951; 11:1269–1275. [10]

Cornfield, J. A statistical problem arising from retrospective studies. In Neyman, J. (Ed.). Proceedings of the Third Berkeley Symposium, IV. 133–148. Berkeley: University of California Press, 1956. [17]

Coste, J., Spira, A., Ducimetiere, P., and Paolaggi, J-B. Clinical and psychological diversity of nonspecific low-back pain. A new approach towards the classification of clinical subgroups. J. Clin. Epidemiol. 1991; 44:1233–1245. [28]

© 2002 by Chapman & Hall/CRC

Coughlin, S.S., Trock, B., Criqui, M.H., Pickle, L.W., Browner, D., and Tefft, M.C. The logistic mod - eling of sensitivity, specificity, and predictive value of a diagnostic test. J. Clin. Epidemiol. 1992; 45:1–7. [21]

Cowie, H., Lloyd, M.H., and Soutar, C.A. Study of lung function data by principal components analysis. Thorax 1985; 40:438–443. [28]

Cox, D.R. Regression models and life tables (with discussion). J. Roy. Statist. Soc. Series B Metho. 1972; 34:187–220. [22]

Crichton, N.J. and Hinde, J.P. Correspondence analysis as a screening method for indicants for clinical diagnosis. Stat. Med. 1989; 8:1351–1362. [28]

Cupples, L.A., Heeren, T., Schatzkin, A., and Colton, T. Multiple testing of hypotheses in comparing two groups. Ann. Intern. Med. 1984; 100:122–129. [25]

Daniel, C. Quoted in Noether, G.E. Non-parametrics: The early years—impressions and recollections. Am. Statist. 1984; 38:173–178. [15]

Davis, B.R. and Hardy, R.J. Data monitoring in clinical trials: The case for stochastic curtailment. J. Clin. Epidemiol. 1994; 47:1033–1042. [25]

Davis, C.E. The effect of regression to the mean in epidemiologic and clinical studies. Am. J. Epidemiol. 1976; 104:493–498. [18]

Dawber, T.R. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge: Harvard University Press (Commonwealth Fund Series), 1980. [25]

Dean, A.G., Dean, J.A., Burton, A.H., and Dicker, R.C. Epi Info, Version 5: A word processing, database, and statistics program for epidemiology and microcomputers. Stone Mountain, GA: USD, Incorporated, 1990. [17]

Decoufle, P., Thomas, T.L., and Pickle, L.W. Comparison of the proportionate mortality ratio and standardized mortality ratio risk measures. Am. J. Epidemiol. 1980; 111:263–269. [26]

De Leeuw, J. Review of Exploratory and multivariate data analysis by Michel Jambu. J. Am. Statist. Assn. 1993; 88:696–697. [6]

Deming, W.E. Review of Statistical papers in honor of Professor George W. Snedecor. New York Statistician 1972; 25(Nov.–Dec.):1–2. [23]

DerSimonian, R. and Laird, N. Meta-analysis in clinical trials. Contr. Clin. Trials 1986; 7:177–188. [25,26]

Detsky, A.S. and Baker, J.P. Analyzing data from ordered categories (Letter to editor). N. Engl. J. Med. 1984; 311:1382–1383. [27]

Detsky A.S. and Sackett, D.L. When was a “negative” clinical trial big enough? How many patients you needed depends on what you found. Arch. Intern. Med. 1985; 145:709–712. [24]

Diamond, G.A., Hirsch, M., Forrester, J.S., Staniloff, H.M., Vas, R., Halpern, S.W., and Swan, H.J.C. Application of information theory to clinical diagnostic testing. Circulation 1981; 63:915. [21] Diggle, P.J., Liang, K-Y., and Zeger, S.L. Analysis of Longitudinal Data. New York: Oxford University

Press, 1994. [22]

Dines, D.E., Elveback, L.R., and McCall, J.T. Zinc, copper, and iron contents of pleural fluid in benign and neoplastic disease. Mayo Clin. Proc. 1974; 49:102–106. [19]

Doll, R. and Hill, A.B. Mortality in relation to smoking: Ten years’ observations of British doctors. Br. Med. J. 1964; 1:1399–1410, 1460–1467. [10]

Dorn, H.F. Methods of analysis for follow-up studies. Hum. Biol. 1950; 22:238–248. [22] Duncan, D.B. Multiple range and multiple F-tests. Biometrics 1955; 11:1–42. [25] Dunn, O.J. Multiple comparisons among means. J. Am. Stat. A. 1961; 56:52–64. [25]

Dunnett, C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. A. 1955; 50:1096–1121. [25]

Dunnett, C.W. and Gent, M. Significance testing to establish equivalence between treatments, with special reference to data in the form of 2 × 2 tables. Biometrics 1977; 33:593–602. [24]

Dwyer, J.H., Feinleib, M., Lippert, P., and Hoffmeister, H. (Eds.), Statistical Models for Longitudinal Studies of Health. New York: Oxford University Press, 1992. [22]

Dyck, P.J., Kratz, K.M., Lehman, K.A. et al. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991; 41:799–807. [29]

© 2002 by Chapman & Hall/CRC

Dyer, A.R., Shipley, M., and Elliott, P. for the INTERSALT Cooperative Research Group. Urinary electrolyte excretion in 24 hours and blood pressure in the INTERSALT Study. I. Estimates of reliability. Am. J. Epidemiol. 1994; 139:927–939. [20]

Eagles, J.M., Beattie, J.A.G., Restall, D.B., Rawlinson, F., Hagen, S., and Ashcroft, G.W. Relation between cognitive impairment and early death in the elderly. Br. Med. J. 1990; 300:239–240. [17] Eddy, D.M. A Manual for Assessing Health Practices and Designing Practice Policies (DRAFT). Lake Forest, IL: John A. Hartford Foundation and the Council of Medical Specialty Societies,

1990. [21]

Ederer, F., Axtell, L.M., and Cutler, S.J. The Relative Survival Rate: A Statistical Methodology. National Cancer Institute Monograph No. 6, Cancer: End Results and Mortality Trends, 1961. [22] Edgington, E.S. Statistical Inference. The Distribution-Free Approach. New York: McGraw-Hill,

1969. [27]

Edmunds, L.H., Jr., Stephenson, L.W., Edie, R.N., and Ratcliffe, M.B. Open-heart surgery in octoge - narians. N. Engl. J. Med. 1988; 319:131–136. [20]

Efron, B. Bootstrap methods: Another look at the jackknife. Ann. Statist. 1979; 7:1–26. [6]

Efron, B. and Diaconis, P. Computer-intensive methods in statistics. Sci. Am. 1983 (May):116–130. [6] Ehrenberg, A.S.C. Data Reduction. Analyzing and Interpreting Statistical Data. London: John Wiley

and Sons, 1975. [2]

Eisenberg, J.M., Schumacher, H.R., Davidson, P.K., and Kaufmann, L. Usefulness of synovial fluid analysis in the evaluation of joint effusions. Use of threshold analysis and likelihood ratios to assess a diagnostic test. Arch. Intern. Med. 1984; 144:715–719. [21]

Elandt-Johnson, R.C. Definition of rates: Some remarks on their use and misuse. Am. J. Epidemiol. 1975; 102:267–271. [17]

Ellenberg, S.S. Meta-analysis: The quantitative approach to research review. Semin. Oncol. 1988; 15:472–481. [25]

Ellison, P.H., Petersen, M.B., Gorman, W.A., and Sharpsteen, D. A comparison of neurological assessment scores from two cohorts of low-birthweight children evaluated at age four years: Dublin and Copenhagen: Neuropediatrics 1992; 23:68–71. [29]

Ellman, M.S. and Feinstein, A.R. Clinical reasoning and the new “non-” nosology. J. Clin. Epidemiol. 1993; 46:577–579. [28]

Elmore, J.G. and Feinstein, A.R. A bibliography of publications on observer variability (final install - ment). J. Clin. Epidemiol. 1992; 45:567–580. [20,21]

Elmore, J.G. and Feinstein, A.R. Joseph Goldberger: An unsung hero of American clinical epidemiology. Ann. Intern. Med. 1994a; 121:372–375. [23]

Elmore, J.G., Wells, C.K., Howard, D.H., and Feinstein, A.R. The impact of clinical history on mammographic interpretations. JAMA 1997; 277:49–52. [20]

Elmore, J.G., Wells, C.K., Lee, C.H., Howard, D.H., and Feinstein, A.R. Variability of radiologists’ interpretations of mammograms. N. Engl. J. Med. 1994b; 331:1493–1499. [20,21]

Ericksen, E.P. and Kadane, J.B. Estimating the population in a census year. 1980 and beyond (with discussion). J. Am. Statist. Assn. 1985; 80:98–131. [17]

Esdaile, J.M., Horwitz, R.I., Levinton, C., Clemens, J.D., Amatruda, J.G., and Feinstein, A.R. Response to initial therapy and new onset as predictors of prognosis in patients hospitalized with congestive heart failure. Clin. Invest. Med. 1992; 15:122–131. [22]

Everitt, B.S. The Analysis of Contingency Tables. New York: John Wiley and Sons, 1977. [14,27] Everitt, B.S. Statistical Methods for Medical Investigations. New York. Oxford University Press. 1989.

pages 25–26. [29]

Everitt, B.S. Cluster Analysis. 3rd ed. London: Edward Arnold, 1993. [28]

Farr, W. Influence of elevation on the fatality of cholera. J. Stat. Soc. 1852; 15:155–183. [23]

Feely, M., Calvert, R., and Gibson, J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 1982; 2:71–73. [25]

Feinstein, A.R. Clinical Judgment. Baltimore: Williams and Wilkins Co., 1967a. [21,28]

Feinstein, A.R. Clinical biostatistics: XVI. The process of prognostic stratification (Part 2). Clin. Pharmacol. Ther. 1972; 13:609–624. [5]

Feinstein, A.R Clinical biostatistics: XX. The epidemiologic trohoc, the abalative risk ratio, and “retrospective” research. Clin. Pharmacol. Ther. 1973; 14:291–307. [17]

© 2002 by Chapman & Hall/CRC

Feinstein, A.R. Clinical biostatistics: XXXIV. The other side of “statistical significance”: Alpha, beta, delta, and the calculation of sample size. Clin. Pharmacol. Ther. 1975; 18:491–505. [23]

Feinstein, A.R. Clinical Epidemiology. The Architecture of Clinical Research. Philadelphia: W.B. Saunders, 1985. [1,10,13,17,21,22,25,26]

Feinstein, A.R. The bias caused by high values of incidence of pl in the odds ratio assumption that 1 − p1 -˜ l. J. Chronic Dis. 1986; 39:485–487. [10]

Feinstein, A.R. Clinimetrics. New Haven: Yale University Press, 1987a. [6,28]

Feinstein, A.R. Quantitative ambiguities in matched versus unmatched analyses of the 2 × 2 table for a case-control study. Int. J. Epidemiol. 1987b; 16 (March):128–134. [26]

Feinstein, A.R. Scientific standards in epidemiologic studies of the menace of daily life. Science 1988a; 242:1257–1263. [25,28]

Feinstein, A.R. The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. J. Clin. Epidemiol. 1990a; 43:109–113. [21,24]

Feinstein, A.R. The unit fragility index: an additional appraisal of “statistical significance” for a contrast of two proportions. J. Clin. Epidemiol. 1990b; 43:201–209. [11]

Feinstein, A.R. Invidious comparisons and unmet clinical challenges (Editorial). Am. J. Med. 1992; 92:117–124. [10]

Feinstein, A.R. “Clinical judgment” revisited: The distraction of quantitative models. Ann. Intern. Med. 1994; 120:799–805. [6,28]

Feinstein, A.R. Meta-analysis: Statistical alchemy for the 21st century. J. Clin. Epidemiol. 1995; 48:71–79. [25]

Feinstein, A.R. Multivariable Analysis. An Introduction. New Haven: Yale University Press. 1996. [11,18,21,26,27,29]

Feinstein, A.R. P-values and confidence intervals: Two sides of the same unsatisfactory coin. J. Clin. Epidemiol. 1998a; 51:355–360. [13]

Feinstein, A.R. The problem of cogent subgroups: A clinicostatistical tragedy (Commentary) . J. Clin. Epidemiol. 1998b; 51:297–299. [25]

Feinstein, A.R. and Cicchetti, D.V. High agreement but low kappa: I. The problems of two paradoxes. J. Clin. Epidemiol. 1990c; 43:543–549. [20]

Feinstein, A.R. and Esdaile, J.M. Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. Am. J. Med. 1987c; 82:113–123. [22]

Feinstein, A.R. and Kwoh, C.K. A box-graph method for illustrating relative-size relationships in a 2 × 2 table. Int. J. Epidemiol. 1988b; 17:222–224. [16]

einstein, A.R. and Stern, E.K. Clinical effects of recurrent attacks of acute rheumatic fever: A prospective epidemiologic study of 105 episodes. J. Chronic Dis. 1967b; 20:13–27. [9]

Feinstein, A.R. and Wells, C.K. A clinical-severity staging system for patients with lung cancer. Medicine 1990d; 69:1–33. [6,27,29]

Feinstein, A.R., Gelfman, N.A., and Yesner, R., with the collaboration of Auerbach, O., Hackel, D.B., and Pratt, P.C. Observer variability in histopathologic diagnosis of lung cancer. Am. Rev. Resp. Dis. 1970; 101:671–684. [20]

Feinstein, A.R., Horwitz, R.I., Spitzer, W.O., and Battista, R.N. Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case-control research. JAMA 1981; 246:957–961. [25]

Fendrich, M. Inconsistent coding of race and ethnicity in infants (Letter to editor). JAMA 1992; 267:3151–3152. [20]

Ferguson, G.A. Nonparametric Trend Analysis. Montreal: McGill University Press, 1965. [27] Fetter, R.B., Shin, Y., Freeman, J.L., Averill, R.F., and Thompson, J.D. Case mix definition by diagnosis-

related groups. Med. Care 1980; 18(Suppl 2):1–53. [21]

Finney, D.J. Whither biometry? In Hoppe, F.M., (Ed.). Multiple Comparisons, Selection, and Applications in Biometry. New York: Marcel Dekker, Inc. 1993. [21]

Fischer, M.A. and Feinstein, A.R. Excess sample size in randomized controlled trials. J. Invest. Med. 1997; 45:198A. [23]

Fisher, P., Greenwood, A., Huskisson, E.C., Turner, P., and Belon, P. Effect of homoeopathic treatment on fibrositis (primary fibromyalgia). Br. Med. J. 1989; 299:365–366. [15]

Fisher, R.A. Statistical Methods for Research Workers. Edinburgh: Oliver and Boyd, 1925. [6,11]

© 2002 by Chapman & Hall/CRC

Fisher, R.A. Statistical Methods for Research Workers. 5th ed. Edinburgh: Oliver and Boyd, 1934. [12,17]

Fisher, R.A. Statistical Methods for Research Workers. 8th ed. Edinburgh: Oliver and Boyd, 1941. [20] Fisher, R.A. Statistical Methods and Scientific Inference. Edinburgh: Oliver and Boyd, 1959. [11,23] Flameng, W., Wouters, L., Sergeant, P., Lewi, P., Borgers, M., Thone, F., and Suy, R. Multivariate analysis of angiographic, histologic, and electrocardiographic data in patients with coronary

heart disease. Circulation 1984; 70:7–17. [28]

Fleiss, J.L. Statistical Methods for Rates and Proportions. 2nd ed. New York: John Wiley and Sons, 1981. (15,17,19,20,23,26]

Fleiss, J.L. Confidence intervals vs. significance tests: Quantitative interpretation (Letter to editor). Am. J. Public Health 1986; 76:587. [13,14]

Fletcher, K.A. on behalf of the Atrial Fibrillation investigators. Pooling data from five stroke prevention clinical trials versus performing a meta-analysis. Controlled Clin. Trials 1993; 14(abstract P 90). [25]

Follman, D., Wittes, J., and Cutler, J.A. The use of subjective rankings in clinical trials with an application to cardiovascular disease. Stat. Med. 1992; 11:427–437. [27]

Food and Drug Administration. The Bioavailability Protocol Guideline for ANDA and NDA Submission. Division of Biopharmaceutics. Rockville, MD:Drug Monographs/Bureau of Drugs, Food and Drug Administration, 1977. [24]

Forrow, L., Taylor, W.C., and Arnold, R.M. Absolutely relative: How research results are summarized can affect treatment decisions. Am. J. Med. 1992; 92:121–124. [10]

Forsythe, A.B. and Frey, H.S. Tests of significance from survival data. Comput. Biomed. Res. 1970; 3:124–132. [22]

Freedman, B. Equipoise and the ethics of clinical research. N. Eng. J. Med. 1987; 317:141–145. [25] Freedman, D.A. Adjusting the 1990 census. Science 1991; 252:1233–1236. [17]

Freedman, L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat. Med. 1982; 1:121–129. [22]

Freedman, L.S. and Spiegelhalter, D.J. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. Statistician 1983; 32:153–160. [25]

Freeman, D.H. and Jekel, J.F. Table selection and log linear models. J. Chronic Dis. 1980; 33:513–524. [27]

Freeman, L.C. Elementary Applied Statistics: For Students in Behavioral Science. New York: John Wiley and Sons, 1965. [27]

Freiman, J.A., Chalmers, T.C., Smith, H., Jr. et al. The importance of beta, the Type II error and sample size in the design and interpretation of the randomized control trial: Survey of 71 ‘negative’ trials. N. Engl. J. Med. 1978; 229:690–694. [23]

Friederici, H.H.R. and Sebastian, M. The concordance score. Correlation of clinical and autopsy findings. Arch. Pathol. Lab. Med. 1984; 108:515–517. [20]

Fritschi, L., Battistutta, D., Strutton, G., and Green, A. A non-invasive measure of photoageing. Int. J. Epidemiol. 1995; 24:150–154. [29]

Fulton, M., Raab, G., Thomson, G., Laxen, D., Hunter, R., and Hepburn, W. Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet 1987; 1:1221–1225. [3]

Furukawa, T. and Sumita, Y. A cluster-analytically derived subtyping of chronic affective disorders. Acta. Psychiatr. Scand. 1992; 85:177–182. [28]

Galton, F. Regression towards mediocrity in hereditary stature. J. Anthropol. Instit. 1885; 15:246–263. [18]

Galton, F. Natural Inheritance. London: Macmillan, 1889. [4,17]

Garber, H.J. Response to Letter to editor. Am. J. Psychiatry 1993; 150:356–357. [23]

Garber, H.J. and Ritvo, E.R. Magnetic resonance imaging of the posterior fossa in autistic adults. Am. J. Psychiatry 1992; 149:245–247. [23]

Gardner, M.J. and Altman, D.G. Confidence intervals rather than P values: Estimation rather than hypothesis testing. Br. Med. J. 1986; 292:746–750. [16]

Gardner, M.J. and Altman, D.G. (Eds.). Statistics with Confidence — Confidence Intervals and Statistical Guidelines. London: British Medical Journal, 1989. [8]

© 2002 by Chapman & Hall/CRC

Gart, J.J. The comparison of proportions: A review of significance tests, confidence intervals, and adjustments for stratification. Rev. Int. Statist. Instit. 1971; 39:148–169. [14]

Gart, J.J. and Thomas, D.G. Numerical results on approximate confidence limits for the odds ratio. J. Roy. Statist. Soc. Series B 1972; 34:441–447. [17]

Gart, J.J. and Thomas, D.G. The performance of three approximate confidence limit methods for the odds ratio. Am. J. Epidemiol. 1982; 115:453–470. [17]

Geary, R.C. Moments of the ratio of the mean deviation to the standard deviation for normal samples. Biometrika 1936; 28:295. [5]

Gehan, E.A. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965; 52:203–223. [22]

Gehan, E.A. Discussion on the paper by R. and J. Peto. J. Roy. Statist. Soc. Series A Stat. 1972; 135:204–205. [22]

Genest, J. Personal communication, 1981. [25]

Gentleman, R. and Crowley, J. Graphical methods for censored data. J. Am. Statist. Assn. 1991; 86:678–683. [22]

Gerbarg, Z.B. and Horwitz, R.I. Resolving conflicting clinical trials: Guidelines for meta-analysis. J. Clin. Epidemiol. 1988; 41:504–509. [25]

Gittlesohn, A. and Royston, P.N. Annotated Bibliography of Cause-of-Death Validation Studies 1958–1980. Washington, DC: U.S. Government Printing Office, 1982. (Vital and health statistics. Series 2: No. 89)(DHHS publication no. [PHS] 82–1363). [17,22]

Glass, G.V., McGaw, B., and Smith, M.L. Meta-Analysis in Social Research. Beverly Hills, CA: Sage Publications, 1981. [10]

Glindmeyer, H.W., Diem, J.E., Jones, R.N., and Weill, H. Noncomparability of longitudinally and cross-sectionally determined annual change in spirometry. Am. Rev. Respir. 1982; 125:544–548. [22]

Godfrey, K. Simple linear regression in medical reserach. N. Engl. J. Med. 1985; 313:1629–1636. [19] Goldman, L. Electrophysiological testing after myocardial infarction. A paradigm for assessing the

incremental value of a diagnostic test. Circulation 1991; 83:1090–1092. [21]

Gonzalez, E.R., Bahal, N., Hansen, L.A., Ware, D., Bull, D.S., Ornato, J.P., and Lehman, M.E. Intermittent injection vs. patient-controlled analgesia for sickle cell crisis pain. Arch. Intern. Med. 1991; 151:1373–1378. [15]

Goodman, L.A. and Kruskal, W.H. Measures of association for cross classifications. J. Am. Statist. Assn. 1954; 49:732–764. [27]

Goodman, S.N. Meta-analysis and evidence. Controlled Clin. Trials 1989; 10:188–204. [25] Goodman, S.N. Multiple comparisons, explained. Am. J. Epidemiol. 1998; 147:807–812. [25] Goodman, S.N. and Berlin, J.A. The use of predicted confidence intervals when planning experiments

and the misuse of power when interpreting results. Ann. Intern. Med. 1994; 121:200–206. [23,24] Goold, S.D., Hofer, T., Zimmerman, M., Hayward, R.A. Measuring physician attitudes toward cost,

uncertainty, malpractice, and utilization review. J. Gen. Intern. Med. 1994; 9:544–549. [28] Gordon, R.S., Jr. Minimizing medical costs (Letter to editor). Arch. Intern. Med. 1983; 143:845. [23] Gould, S.G. The Mismeasure of Man. New York: W.W. Norton, 1981. [28]

Greene, M.K., Kerr, A.M., McIntosh, I.B., and Prescott, R.J. Acetazolamide in prevention of acute mountain sickness: A double-blind controlled cross-over study. Br. Med. J. 1981; 282:811–813. [27]

Greene, W.L., Feinstein, A.R., and Concato, J. Claims of equivalence in medical research: Are they supported by evidence? Ann. Int. Med. 2000; 132:715–722. [24]

Greenland, S. RE: “A simple method to calculate the confidence interval of a standardized mortality ratio (SMR)” (Letter to editor). Am. J. Epidemiol. 1991; 133:212–213. [26]

Greenland, S. and Longnecker, M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am. J. Epidemiol. 1992; 125:1301–1309. [25]

Greenwald, P., Barlow, J.J., Nasca, P.C. et al. Vaginal cancer after maternal treatment with synthetic estrogens. N. Engl. J. Med. 1971; 285:390–392. [17]

Greenwood, M. The “errors of sampling” of the survivorship tables. In Reports on Public Health and Medical Subjects, No. 33, App. 1, London: H.M. Stationery Office, 1926. [22]

© 2002 by Chapman & Hall/CRC

Griffiths, D. A pragmatic approach to Spearman’s rank correlation coefficient. Teach. Statist. 1980; 2:10–13. [27]

Griner, P.F., Mayewski, R.J., Mushlin, A.I., and Greenland, P. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann. Intern. Med. 1981; 94:553–600. [21]

Guilford, J.P. Fundamental Statistics in Psychology and Education. New York: McGraw-Hill, 1956. [19]

GUSTO III Investigators. Global use of strategies to open occluded coronary arteries. A comparison of reteplase with alteplase for acute myocardial infarction. N. Engl. J. Med. 1997; 337:1118–1123. [24]

Guttman, L. An outline of the statistical theory of prediction. In Horst, P. (Ed.). The Prediction of Personal Adjustment. New York. Social Science Research Council 1941. [27]

Guyatt, G., Sackett, D., Adachi, J., Roberts, R., Chong, J., Rosenbloom, D., and Keller, J. A clinician’s guide for conducting randomized trials in individual patients. Can. Med. Assoc. J. 1988; 139:497–503. [25]

Guyatt, G., Sackett, D., Taylor, D.W., Chong, J., Roberts, R., and Pugsley, S. Determining optimal therapy: Randomized trials in individual patients. N. Engl. J. Med. 1986; 314:889–892. [25]

Hadi, A.S. and Ling, R.F. Some cautionary notes on the use of principal components regression. Am. Stat. 1998; 52:15–19. [28]

Hafkenscheid, A. Reliability of a standardized and expanded Brief Psychiatric Rating Scale: a replication study. Acta Psychiatr. Scand. 1993; 88:305–310. [29]

Hall, G., Chowdhury, S., and Bloem, M. Use of mid-upper-arm circumference Z scores in nutritional assessment (Letter to editor). Lancet 1993; 341:1481. [4]

Hamilton, D.P. Census adjustment battle heats up. Science 1990; 248:807–808. [17]

Hammond, E.C. and Horn, D. Smoking and death rates—Report on forty-four months of followup of 187,783 men. JAMA 1958; I. Total mortality 166:1159–1172. II. Death rates by cause 166:1294–1308. [13]

Hansen, K.M. and Tukey, J.W. Tuning a major part of a clustering algorithm. Int. Stat. Rev. 1992; 60:21–44. [28]

Harrell, F.E., Jr., Lee, K.L., Califf, R.M., Pryor, D.B., and Rosati, R.A. Regression modelling strategies for improved prognostic prediction. Stat. Med. 1984; 3:143–152. [28]

Harrell, F.E., Jr., Lee, K.L., Matchar, D.B., and Reichert, T.A. Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat. Rep. 1985; 69:1071–1077. [8]

Harris, J.E., Wente, E.F., Cox, C.F., Nawaway, I.E., Kowalski, C.J., Storey, A.T., Russell, W.R., Pointz, P.V., and Walter, G.F. Mummy of the “elder lady” in the tomb of Amenhotep II: Egyptian Museum catalog number 61070. Science 1978; 200:1149–1151. [28]

Hartigan, J.A. Clustering. Annu. Rev. Biophys. 1973; 2:81–101. [28]

Harvey, M., Horwitz, R.I., and Feinstein, A.R. Diagnostic bias and toxic shock syndrome. Am. J. Med. 1984; 76:351–360. [20]

Haybittle, J.L. Repeated assessment of results in clinical trials of cancer treatment. Br. J. Radiol. 1971; 44:793–797. [25]

Haybittle, J.L. and Freedman, L.S. Some comments on the logrank test statistic in clinical trial applications. Statistician 1979; 28:199–208. [22]

Healy, M.J.R. and Goldstein, H. Regression to the mean. Ann. Hum. Biol. 1978; 5:277–280. [18] Hedges, L.V. and Olkin, I. Statistical Methods for Meta-Analysis. San Diego: Academic Press, Inc.,

1985. [25]

Heinonen, O.P. , Shapiro, S., Tuominen, L. et al. Reserpine use in relation to breast cancer. Lancet 1974; 2:675–677. [25]

Heinrich, I., O’Hara, H., Sweetman, B., and Anderson, J.A.D. Validation aspects of an empirically derived classification for non-specific low back pain. Statistician 1985; 34:215–230. [28] Henderson, W.G., Fisher, S.G., Cohen, N., Waltzman, S., Weber, L., and the VA Cooperative Study

Group on Cochlear Implantation. Use of principal components analysis to develop a composite score as a primary outcome variable in a clinical trial. Controlled Clin. Trials. 1990; 11:199–214. [28]

© 2002 by Chapman & Hall/CRC